These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 18606202)

  • 1. Differential intra-endothelial delivery of polymer nanocarriers targeted to distinct PECAM-1 epitopes.
    Garnacho C; Albelda SM; Muzykantov VR; Muro S
    J Control Release; 2008 Sep; 130(3):226-33. PubMed ID: 18606202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow shear stress differentially regulates endothelial uptake of nanocarriers targeted to distinct epitopes of PECAM-1.
    Han J; Shuvaev VV; Davies PF; Eckmann DM; Muro S; Muzykantov VR
    J Control Release; 2015 Jul; 210():39-47. PubMed ID: 25966362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RhoA activation and actin reorganization involved in endothelial CAM-mediated endocytosis of anti-PECAM carriers: critical role for tyrosine 686 in the cytoplasmic tail of PECAM-1.
    Garnacho C; Shuvaev V; Thomas A; McKenna L; Sun J; Koval M; Albelda S; Muzykantov V; Muro S
    Blood; 2008 Mar; 111(6):3024-33. PubMed ID: 18182571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination-targeting to multiple endothelial cell adhesion molecules modulates binding, endocytosis, and in vivo biodistribution of drug nanocarriers and their therapeutic cargoes.
    Papademetriou I; Tsinas Z; Hsu J; Muro S
    J Control Release; 2014 Aug; 188():87-98. PubMed ID: 24933603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collaborative enhancement of antibody binding to distinct PECAM-1 epitopes modulates endothelial targeting.
    Chacko AM; Nayak M; Greineder CF; Delisser HM; Muzykantov VR
    PLoS One; 2012; 7(4):e34958. PubMed ID: 22514693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PECAM-targeted delivery of SOD inhibits endothelial inflammatory response.
    Shuvaev VV; Han J; Yu KJ; Huang S; Hawkins BJ; Madesh M; Nakada M; Muzykantov VR
    FASEB J; 2011 Jan; 25(1):348-57. PubMed ID: 20876216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of flow on endothelial endocytosis of nanocarriers targeted to ICAM-1.
    Bhowmick T; Berk E; Cui X; Muzykantov VR; Muro S
    J Control Release; 2012 Feb; 157(3):485-92. PubMed ID: 21951807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and chronic shear stress differently regulate endothelial internalization of nanocarriers targeted to platelet-endothelial cell adhesion molecule-1.
    Han J; Zern BJ; Shuvaev VV; Davies PF; Muro S; Muzykantov V
    ACS Nano; 2012 Oct; 6(10):8824-36. PubMed ID: 22957767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Size and targeting to PECAM vs ICAM control endothelial delivery, internalization and protective effect of multimolecular SOD conjugates.
    Shuvaev VV; Muro S; Arguiri E; Khoshnejad M; Tliba S; Christofidou-Solomidou M; Muzykantov VR
    J Control Release; 2016 Jul; 234():115-23. PubMed ID: 27210108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collaborative Enhancement of Endothelial Targeting of Nanocarriers by Modulating Platelet-Endothelial Cell Adhesion Molecule-1/CD31 Epitope Engagement.
    Chacko AM; Han J; Greineder CF; Zern BJ; Mikitsh JL; Nayak M; Menon D; Johnston IH; Poncz M; Eckmann DM; Davies PF; Muzykantov VR
    ACS Nano; 2015 Jul; 9(7):6785-93. PubMed ID: 26153796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers.
    Muro S; Garnacho C; Champion JA; Leferovich J; Gajewski C; Schuchman EH; Mitragotri S; Muzykantov VR
    Mol Ther; 2008 Aug; 16(8):1450-8. PubMed ID: 18560419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cells.
    Wiewrodt R; Thomas AP; Cipelletti L; Christofidou-Solomidou M; Weitz DA; Feinstein SI; Schaffer D; Albelda SM; Koval M; Muzykantov VR
    Blood; 2002 Feb; 99(3):912-22. PubMed ID: 11806994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ICAM-1 recycling in endothelial cells: a novel pathway for sustained intracellular delivery and prolonged effects of drugs.
    Muro S; Gajewski C; Koval M; Muzykantov VR
    Blood; 2005 Jan; 105(2):650-8. PubMed ID: 15367437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-endothelial cell adhesion molecule-1-directed immunotargeting to cardiopulmonary vasculature.
    Scherpereel A; Rome JJ; Wiewrodt R; Watkins SC; Harshaw DW; Alder S; Christofidou-Solomidou M; Haut E; Murciano JC; Nakada M; Albelda SM; Muzykantov VR
    J Pharmacol Exp Ther; 2002 Mar; 300(3):777-86. PubMed ID: 11861781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Streptavidin facilitates internalization and pulmonary targeting of an anti-endothelial cell antibody (platelet-endothelial cell adhesion molecule 1): a strategy for vascular immunotargeting of drugs.
    Muzykantov VR; Christofidou-Solomidou M; Balyasnikova I; Harshaw DW; Schultz L; Fisher AB; Albelda SM
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2379-84. PubMed ID: 10051650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of Collaborative Enhancement of Binding of Paired Antibodies to Distinct Epitopes of Platelet Endothelial Cell Adhesion Molecule-1.
    Kiseleva R; Greineder CF; Villa CH; Hood ED; Shuvaev VV; Sun J; Chacko AM; Abraham V; DeLisser HM; Muzykantov VR
    PLoS One; 2017; 12(1):e0169537. PubMed ID: 28085903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ICAM-1 targeting, intracellular trafficking, and functional activity of polymer nanocarriers coated with a fibrinogen-derived peptide for lysosomal enzyme replacement.
    Garnacho C; Muro S
    J Drug Target; 2017; 25(9-10):786-795. PubMed ID: 28665212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies against the first Ig-like domain of human platelet endothelial cell adhesion molecule-1 (PECAM-1) that inhibit PECAM-1-dependent homophilic adhesion block in vivo neutrophil recruitment.
    Nakada MT; Amin K; Christofidou-Solomidou M; O'Brien CD; Sun J; Gurubhagavatula I; Heavner GA; Taylor AH; Paddock C; Sun QH; Zehnder JL; Newman PJ; Albelda SM; DeLisser HM
    J Immunol; 2000 Jan; 164(1):452-62. PubMed ID: 10605042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1.
    Muro S; Wiewrodt R; Thomas A; Koniaris L; Albelda SM; Muzykantov VR; Koval M
    J Cell Sci; 2003 Apr; 116(Pt 8):1599-609. PubMed ID: 12640043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms that determine nanocarrier targeting to healthy versus inflamed lung regions.
    Brenner JS; Bhamidipati K; Glassman PM; Ramakrishnan N; Jiang D; Paris AJ; Myerson JW; Pan DC; Shuvaev VV; Villa CH; Hood ED; Kiseleva R; Greineder CF; Radhakrishnan R; Muzykantov VR
    Nanomedicine; 2017 May; 13(4):1495-1506. PubMed ID: 28065731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.